Inventor · disambiguated record
Roland Gendron
Also filed as: GENDRON ROLAND
76 granted patents·5 pending applications·970 citations·filing 2005–2025
99Inventor score
Files withTHERAVANCE INC24THERAVANCE BIOPHARMA R&D IP LLC19ALLEGRETTI PAUL9FLEURY MELISSA7CHOI SEOK-KI6
Top patents by PatentIndex Score
81 records- 0198US8691868B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2012·Granted Apr 8, 2014·57 cites·31 claims
- 0298US8586536B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2011·Granted Nov 19, 2013·72 cites·26 claims
- 0398US8513244B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2012·Granted Aug 20, 2013·79 cites·20 claims
- 0498US8481044B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Jul 9, 2013·67 cites·29 claims
- 0598US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0697US8449890B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted May 28, 2013·68 cites·26 claims
- 0797US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 0897US7834041B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·29 cites·24 claims
- 0996US8686184B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Apr 1, 2014·61 cites·25 claims
- 1096US8563512B2Neprilysin inhibitorsSMITH CAMERON·Filed 2011·Granted Oct 22, 2013·62 cites·22 claims
- 1194US10759813B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Sep 1, 2020·3 cites·18 claims
- 1294US9845332B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Dec 19, 2017·7 cites·1 claims
- 1394US9120747B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2013·Granted Sep 1, 2015·16 cites·16 claims
- 1494US8846913B2Neprilysin inhibitorsTHERAVANCE INC·Filed 2013·Granted Sep 30, 2014·18 cites·10 claims
- 1594US7989484B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Aug 2, 2011·25 cites·21 claims
- 1694US7956054B2Dual-acting pyrazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Jun 7, 2011·21 cites·16 claims
- 1794US7863309B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Jan 4, 2011·27 cites·27 claims
- 1894US7759363B2Benzimidazole-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jul 20, 2010·18 cites·18 claims
- 1994US7396933B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Jul 8, 2008·28 cites·13 claims
- 2094US7351704B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Apr 1, 2008·25 cites·19 claims
- 2193US7419989B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Sep 2, 2008·19 cites·12 claims
- 2292US10336773B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 2, 2019·5 cites·6 claims
- 2392US9688692B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Jun 27, 2017·7 cites·11 claims
- 2492US9388145B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2015·Granted Jul 12, 2016·8 cites·9 claims
- 2592US8377964B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·10 cites·17 claims
- 2692US8158659B2Dual-acting imidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2010·Granted Apr 17, 2012·11 cites·32 claims
- 2792US7317022B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonistsTHERAVANCE INC·Filed 2006·Granted Jan 8, 2008·19 cites·15 claims
- 2890US10744104B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 18, 2020·2 cites·20 claims
- 2990US9499487B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Nov 22, 2016·12 cites·10 claims
- 3088US12016835B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Jun 25, 2024·0 cites·16 claims
- 3188US9682052B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2015·Granted Jun 20, 2017·4 cites·37 claims
- 3288US7498442B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2008·Granted Mar 3, 2009·10 cites·10 claims
- 3388US7446114B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Nov 4, 2008·10 cites·15 claims
- 3487US11261197B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Mar 1, 2022·1 cites·20 claims
- 3587US10123984B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Nov 13, 2018·3 cites·10 claims
- 3686US9150500B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2014·Granted Oct 6, 2015·5 cites·32 claims
- 3786US8344013B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 1, 2013·4 cites·7 claims
- 3886US8236846B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Aug 7, 2012·5 cites·24 claims
- 3985US7875629B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jan 25, 2011·6 cites·11 claims
- 4084US8569351B2Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2012·Granted Oct 29, 2013·3 cites·3 claims
- 4183US8895755B2Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2013·Granted Nov 25, 2014·3 cites·1 claims
- 4283US8349875B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 8, 2013·3 cites·24 claims
- 4383US8080572B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Dec 20, 2011·5 cites·22 claims
- 4482US9012485B2Dual-acting imidazole antihypertensive agentsCHOI SEOK-KI·Filed 2014·Granted Apr 21, 2015·2 cites·6 claims
- 4582US8119634B2Dual-acting pyrazole antihypertensive agentsBLAIR BROOKE·Filed 2011·Granted Feb 21, 2012·6 cites·11 claims
- 4682US7772239B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2007·Granted Aug 10, 2010·4 cites·16 claims
- 4781US11851443B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Dec 26, 2023·0 cites·19 claims
- 4881US9334245B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2014·Granted May 10, 2016·3 cites·22 claims
- 4981US2022274957A1Benzimidazole-carboxamide compounds as 5-ht4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 5080US9771337B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Sep 26, 2017·2 cites·4 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →